Leukemia, T-cell, Chronic - 25 Studies Found
Recruiting |
: Ruxolitinib for Adult T-Cell Leukemia :
: 2016-02-20 : Biological: IL-15 plus alemtuzumab rhIL-15 by s.c. injection Monday-Friday over two weeks; followed by a |
Completed |
: Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 : Adult T-cell Leukemia-Lymphoma : 2010-07-30 :
|
Completed |
: Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) : HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL) : 2011-08-16 : Drug: CHOP-daclizumab Other Name: CHOP-Zenapax |
Completed |
: Anti-Tac for Treatment of Leukemia :
: 2000-01-18 : Biological: daclizumab Other Name: Zenapax |
Recruiting |
: Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma :
|
Terminated |
: Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma :
: 2008-06-13 : Drug: Panobinostat (LBH589) 20mg/day p.o. on three times-a- week |
Completed |
: Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) : T-cell-prolymphocytic Leukemia : 2010-08-20 :
|
Terminated |
: Zidovudine, Interferon Alfa-2b, and PEG-Interferon Alfa-2b in Treating Patients With Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia/Lymphoma :
: 2009-02-28 :
|
Completed |
: Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia : Leukemia, Adult T-Cell : 2005-07-07 : Biological: Denileukin diftitox (Ontak) Patients will be treated with Denileukin Diftitox 9 mcg/kg/d int |